+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Contract Research Organizations Global Market Opportunities And Strategies To 2021

  • ID: 4605298
  • Report
  • Region: Global
  • 250 Pages
  • The Business Research Company
1 of 5
The CRO Production in the North America is Worth $18.8 Billion Accounting for 42.3% of the Global CRO Production,

FEATURED COMPANIES

  • 2Y-Chem
  • Aurigene
  • Eurotrials
  • IQVIA
  • North America:
  • PRA
  • MORE

A Contract Research Organization (CRO) is a service provider, which offers end-to-end solutions in conducting clinical trials for biopharmaceutical and medical device companies. The core services offered by CROs to biopharmaceutical companies include initial drug discovery solutions, toxicology studies, bio-analytical services, central laboratory, site monitoring, data management services, vigilance, bio-statistics, study and development program design and consulting, regulatory affairs and a variety of post-marketing surveillance services. Many pharmaceutical companies often outsource their R&D activities to CROs and is expected that these companies will increase their outsourcing activities for drug development process to CROs in future.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description
Where is the largest and fastest growing market for CRO? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward?  The CRO global market report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, porters five force model, segmentation, regional and country breakdowns, competitive landscape, market shares, customer information, key mergers and acqisitions, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints cover the external factors supporting and controlling the growth of the market.
  • Porters five force model covers the threat of new entrants, threat of substitutes, bargaining power of buyers, bargaining power of suppliers and industry competition for the CRO market.
  • Market segmentation by service breaks down the market into sub markets. By service type, the market is segmented into drug discovery, preclinical studies, phase 1, phase 2, phase 3 ,phase 4, others . Market segmentation is also done by type of therapeutic area, which includes oncology, cardiovascular disease, CNS disorder, infectious disease, metabolic disease and others. The historic and forecast growth rates for these segments are also covered in this report.
  • The regional and country breakdown section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets.
  • The competitive landscape section gives a description of the competitive nature of the market, market shares, and a Description of the leading companies in terms of their offerings, growth strategy and financial performance.
  • The customer information section covers major surveys conducted on the global CRO market and their implications.
  • The report also covers key mergers and acquisitions in the CRO market. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets covered:

1) By Type of Services - drug discovery, preclinical studies, phase 1, phase 2, phase 3 ,phase 4 and others 

2) By Therapeutic Area - oncology, cardiovascular disease, CNS disorder, infectious disease, metabolic disease and others

Companies mentioned: IQVIA, Laboratory Corporation of America Holdings, ICON Plc , PAREXEL and PPD.

Countries: USA, UK, Germany, France, Italy, Spain, Russia, Brazil, Australia, China, India, Japan

Regions: Asia-Pacific, North America, South America, Western Europe, Eastern Europe, Middle East & Africa.

Time series: Five years historic and forecast.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

The report covers production and consumption revenue data for CROs providing outsourced pharmaceutical, biologics and medical research services. Production revenues are based on where the services are produced, e.g the country where the CRO services occur. Consumption revenues are based on where the services are sold irrespective of where the goods or services are produced. This differentiation affects only where revenues are recognized by geography and does not apply to the global numbers.

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 2Y-Chem
  • Aurigene
  • Eurotrials
  • IQVIA
  • North America:
  • PRA
  • MORE

1. Executive Summary

2. Contract Research Organizations Market Characteristics

3. Porter’s Five Forces Analysis

4. Global CRO Market Size And Growth
4.1. Global CRO Market Historic Market Growth, Value
4.1.1. Drivers Of The Market
4.1.2. Restraints On The Market
4.2. Global CRO Market Forecast Growth, Value
4.2.1. Drivers Of The Market
4.2.2. Restraints On The Market

5. Global CRO Market Segmentation
5.1. Global CRO Market, Segmentation By Service Type
Drug discovery
Preclinical studies
Phase I
Phase II
Phase III
Phase IV
Other Services
5.2. Global CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
5.3. Global CRO Production, Segmentation By Therapeutic Area
Oncology
Infectious diseases
Central nervous system
Cardiovascular diseases
Metabolic Disease
Other Therapeutic Area
5.4. Global CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
5.5. Global CRO Market, 2017, By Region
5.6. Global CRO Market, 2013-2021, Historic And Forecast Growth Rate, By Region
5.7. Global CRO Market, 2017, By Country
5.8. Global CRO Market, 2013-2017, Historic And Forecast Growth Rate, By Country

6. Global CRO Market Comparison with Macro Economic Factors
6.1. CRO Market Size, Percentage of GDP, By Country
6.2. Per Capita Average CRO Expenditure, By Country

7. North America CRO Market Overview
7.1. North America CRO Market Information
7.2. North America CRO Production Historic Market Growth, Value
7.3. North America CRO Production Forecast Growth, Value
7.4. North America CRO Production, Segmentation By Service Type
7.5. North America CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
7.6. North America CRO Production, Segmentation By Therapeutic Area
7.7. North America CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
7.8. North America CRO Consumption Historic Market Growth, Value
7.9. North America CRO Consumption Forecast Growth, Value
7.1. USA CRO Market Overview
7.10.1. USA CRO Market Information
7.10.2. USA CRO Production Historic Market Growth, Value
7.10.3. USA CRO Production Forecast Growth, Value
7.10.4. USA CRO Production, Segmentation By Service Type
7.10.5. USA CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
7.10.6. USA CRO Production, Segmentation By Therapeutic Area
7.10.7. USA CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
7.10.8. USA CRO Consumption Historic Market Growth, Value
7.10.9. USA CRO Consumption Forecast Growth, Value

8. Asia-Pacific CRO Market Overview
8.1. Asia-Pacific CRO Market Information
8.2. Asia-Pacific CRO Production Historic Market Growth, Value
8.3. Asia-Pacific CRO Production Market Forecast Growth, Value
8.4. Asia-Pacific CRO Production, Segmentation By Service Type
8.5. Asia-Pacific CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
8.6. Asia-Pacific CRO Production, Segmentation By Therapeutic Area
8.7. Asia-Pacific CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
8.8. Asia-Pacific CRO Consumption Historic Market Growth, Value
8.9. Asia-Pacific CRO Consumption Market Forecast Growth, Value
8.1. China CRO Market Overview
8.10.1. China CRO Market Information
8.10.2. China CRO Production Historic Market Growth, Value
8.10.3. China CRO Production Forecast Growth, Value
8.10.4. China CRO Production, Segmentation By Service Type
8.10.5. China CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
8.10.6. China CRO Production, Segmentation By Therapeutic Area
8.10.7. China CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
8.10.8. China CRO Consumption Historic Market Growth, Value
8.10.9. China CRO Consumption Forecast Growth, Value
8.11. India CRO Market Overview
8.11.1. India CRO Market Information
8.11.2. India CRO Production Historic Market Growth, Value
8.11.3. India CRO Production Forecast Growth, Value
8.11.4. India CRO Production, Segmentation By Service Type
8.11.5. India CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
8.11.6. India CRO Production, Segmentation By Therapeutic Area
8.11.7. India CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
8.11.8. India CRO Consumption Historic Market Growth, Value
8.11.9. India CRO Consumption Forecast Growth, Value
8.12. Japan CRO Market Overview
8.12.1. Japan CRO Market Information
8.12.2. Japan CRO Production Historic Market Growth, Value
8.12.3. Japan CRO Production Forecast Growth, Value
8.12.4. Japan CRO Production, Segmentation By Service Type
8.12.5. Japan CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
8.12.6. Japan CRO Production, Segmentation By Therapeutic Area
8.12.7. Japan CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
8.12.8. Japan CRO Consumption Historic Market Growth, Value
8.12.9. Japan CRO Consumption Forecast Growth, Value
8.13. Australia CRO Market Information
8.13.1. Australia CRO Production Historic Growth, Value
8.13.2. Australia CRO Production Forecast Growth, Value
8.13.3. Australia CRO Production, Segmentation By Service Type
8.13.4. Australia CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
8.13.5. Australia CRO Production, Segmentation By Therapeutic Area
8.13.6. Australia CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
8.13.7. Australia CRO Consumption Historic Growth, Value
8.13.8. Australia CRO Consumption Forecast Growth, Value

9. Western Europe CRO Market Overview
9.1. Western Europe CRO Market Information
9.2. Western Europe CRO Production Historic Growth, Value
9.3. Western Europe CRO Production Forecast Growth, Value
9.4. Western Europe CRO Production, Segmentation By Service Type
9.5. Western Europe CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
9.6. Western Europe CRO Production, Segmentation By Therapeutic Area
9.7. Western Europe CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
9.8. Western Europe CRO Consumption Historic Growth, Value
9.9. Western Europe CRO Consumption Forecast Growth, Value
9.1. UK CRO Market Overview
9.10.1. UK CRO Market Information
9.10.2. UK CRO Production Historic Growth, Value
9.10.3. UK CRO Production Forecast Growth, Value
9.10.4. UK CRO Production, Segmentation By Service Type
9.10.5. UK CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
9.10.6. UK CRO Production, Segmentation By Therapeutic Area
9.10.7. UK CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
9.10.8. UK CRO Consumption Historic Growth, Value
9.10.9. UK CRO Consumption Forecast Growth, Value
9.11. Germany CRO Market Information
9.11.1. Germany CRO Production Historic Market Growth, Value
9.11.2. Germany CRO Production Forecast Growth, Value
9.11.3. Germany CRO Production, Segmentation By Service Type
9.11.4. Germany CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
9.11.5. Germany CRO Production, Segmentation By Therapeutic Area
9.11.6. Germany CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
9.11.7. Germany CRO Consumption Historic Market Growth, Value
9.11.8. Germany CRO Consumption Forecast Growth, Value
9.12. France CRO Market Information
9.12.1. France CRO Production Historic Market Growth, Value
9.12.2. France CRO Production Forecast Growth, Value
9.12.3. France CRO Production, Segmentation By Service Type
9.12.4. France CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
9.12.5. France CRO Production, Segmentation By Therapeutic Area
9.12.6. France CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
9.12.7. France CRO Consumption Historic Market Growth, Value
9.12.8. France CRO Consumption Forecast Growth, Value
9.13. Spain CRO Market Information
9.13.1. Spain CRO Production Historic Market Growth, Value
9.13.2. Spain CRO Production Forecast Growth, Value
9.13.3. Spain CRO Production, Segmentation By Service Type
9.13.4. Spain CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
9.13.5. Spain CRO Production, Segmentation By Therapeutic Area
9.13.6. Spain CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
9.13.7. Spain CRO Consumption Historic Market Growth, Value
9.13.8. Spain CRO Consumption Forecast Growth, Value
9.14. Italy CRO Market Information
9.13.1. Italy CRO Production Historic Market Growth, Value
9.13.2. Italy CRO Production Forecast Growth, Value
9.13.3. Italy CRO Production, Segmentation By Service Type
9.13.4. Italy CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
9.13.5. Italy CRO Production, Segmentation By Therapeutic Area
9.13.6. Italy CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
9.13.7. Italy CRO Consumption Historic Market Growth, Value
9.13.8. Italy CRO Consumption Forecast Growth, Value

10. Eastern Europe CRO Market Overview
10.1. Eastern Europe CRO Market Information
10.2. Eastern Europe CRO Production Historic Market Growth, Value
10.3. Eastern Europe Production Forecast Growth, Value
10.4. Eastern Europe CRO Production, Segmentation By Service Type
10.5. Eastern Europe CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
10.6. Eastern Europe CRO Production, Segmentation By Therapeutic Area
10.7. Eastern Europe CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
10.8. Eastern Europe CRO Consumption Historic Market Growth, Value
10.9. Eastern Europe Consumption Forecast Growth, Value
10.1. Russia CRO Market Information
10.10.1. Russia CRO Production Historic Growth, Value
10.10.2. Russia CRO Production Forecast Growth, Value
10.10.3. Russia CRO Production, Segmentation By Service Type
10.10.4. Russia CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
10.10.5. Russia CRO Production, Segmentation By Therapeutic Area
10.10.6. Russia CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
10.10.7. Russia CRO Consumption Historic Growth, Value
10.10.8. Russia CRO Consumption Forecast Growth, Value

11. South America CRO Market Overview
11.1. South America CRO Market Information
11.2. South America CRO Production Historic Growth, Value
11.3. South America CRO Production Forecast Growth, Value
11.4. South America CRO Production, Segmentation By Service Type
11.5. South America CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
11.6. South America CRO Production, Segmentation By Therapeutic Area
11.7. South America CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
11.8. South America CRO Consumption Historic Growth, Value
11.9. South America CRO Consumption Forecast Growth, Value
11.1. Brazil CRO Market Information
11.10.1. Brazil CRO Production Historic Growth, Value
11.10.2. Brazil CRO Production Forecast Growth, Value
11.10.3. Brazil CRO Production, Segmentation By Service Type
11.10.4. Brazil CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
11.10.5. Brazil CRO Production, Segmentation By Therapeutic Area
11.10.6. Brazil CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
11.10.7. Brazil CRO Consumption Historic Growth, Value
11.10.8. Brazil CRO Consumption Forecast Growth, Value

12. Middle East CRO Market Overview
12.1. Middle East CRO Market Information
12.2. Middle East CRO Production Historic Growth, Value
12.3. Middle East CRO Production Forecast Growth, Value
12.4. Middle East CRO Production, Segmentation By Service Type
12.5. Middle East CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
12.6. Middle East CRO Production, Segmentation By Therapeutic Area
12.7. Middle East CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
12.8. Middle East CRO Consumption Historic Growth, Value
12.9. Middle East CRO Consumption Forecast Growth, Value

13. Africa CRO Market Overview
13.1. Africa CRO Market Information
13.2. Africa CRO Production Historic Growth, Value
13.3. Africa CRO Production Forecast Growth, Value
13.4. Africa CRO Production, Segmentation By Service Type
13.5. Africa CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Service Type
13.6. Africa CRO Production, Segmentation By Therapeutic Area
13.7. Africa CRO Production, 2013-2021, Historic And Forecast Growth Rate, By Therapeutic Area
13.8. Africa CRO Consumption Historic Growth, Value
13.9. Africa CRO Consumption Forecast Growth, Value

14. Key M&A and Strategic Partnerships in The Global CRO Market

15. CRO Market Competitive Landscape
15.1. Competitive Analysis Of Global CRO Market Players
15.1.1. Key Players In Preclinical And Clinical Development
15.2. Company Profiles
15.2.1. IQVIA
15.2.2. Laboratory Corporation Of America Holdings
15.2.3. ICON Plc
15.2.4. PAREXEL International Corporation
15.2.5. Pharmaceutical Product Development (PPD), Inc.

16. Customer Information

17. Global CRO Market Segmentation By End-Users
17.1. CRO Market Trends And Strategies

18. Appendix
18.1. Market Data Sources
18.2. Primary Research – Interview Transcripts
18.2.1. Interview – 1
18.2.2. Interview – 2
18.3. Research Methodology
18.4. Note on Currency Conversions
18.5. Research Inquiries
18.6. The publisher
18.7. Copyright and Disclaimer

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • 2Y-Chem
  • Aurigene
  • Eurotrials
  • IQVIA
  • North America:
  • PRA
  • MORE

A Contract Research Organization (CRO) is a service provider, which offers end-to-end solutions in conducting clinical trials for biopharmaceutical and medical device companies. The core services offered by CROs to biopharmaceutical companies include initial drug discovery solutions, toxicology studies, bio-analytical services, central laboratory, site monitoring, data management services, vigilance, bio-statistics, study and development program design and consulting, regulatory affairs and a variety of post-marketing surveillance services.

Many pharmaceutical companies often outsource their R&D activities to CROs and is expected that these companies will increase their outsourcing activities for drug development process to CROs in future.

The CRO production in the North America is worth $18.8 billion accounting for 42.3% of the global CRO production, while the CRO consumption in the North America is worth $20.8 billion which accounted for about 46.8% of the global CRO consumption. The large market size can be attributed to the presence of a large number of pharmaceutical companies and large drug development activity in the region. The difference can be explained by the use of lowercost offshore locations for some CRO activities by US pharmaceutical firms, although the majority of outsourced activity remains within the US market.

By service type, drug discovery was the largest segment in 2017, which accounted for about 33.2% of the CRO market. By therapeutic area, oncology was the largest segment in 2017, which accounted for about 25.1% of the CRO market.

The declining growth of the pharmaceutical market is affecting the CRO industry. Recently, the double digit growth rates of pharmaceutical and biotechnology companies have been shrinking to single digit and R&D productivity also declining owing to drug launch delays and FDA rejections in approval of drugs. Pharmaceutical and biotechnology companies have been encountered with the major task of minimizing their drug costs which had forced most of them to evaluate cost saving options such as outsourcing. Several companies in this sector have already adopted this strategy to outsource their processes to specialist service providers such as CROs. This strategy will help the players to free up their in-house resources for other crucial projects and bring about improved efficiency in terms of timelines, regulatory norms and costs.

Some of the other major trends in the CRO industry include the following –

  • Increasing focus on emerging markets such as China, India and Brazil.
  • Strategic partnerships between CROs and their sponsors
  • Growing investments in technology

IQVIA was the largest player in the global CRO market with 12.4% share, followed by Laboratory Corporation of America Holdings, ICON Plc, PAREXEL and PPD.

Note: Product cover images may vary from those shown
5 of 5

North America:

  • Altasciences
  • BioPharma Services
  • Charles River Laboratories
  • Inflamax Research
  • IQVIA
  • Laboratory Corporation of America Holdings
  • PAREXEL International Corporation
  • Pharmaceutical Product Development
  • PRA Health Sciences
  • Syneos Health

Asia-Pacific:

  • 2Y-Chem
  • A2 Healthcare Corporation
  • AC Medical Inc.
  • Aurigene
  • GVK Bio Ltd.
  • Mediscience Planning
  • Shanghai Genomics Inc.
  • Shanghai Hua Xin Biotech Inc.
  • Shanghai LeadDiscovery Pharma
  • Suven Life Sciences
  • Syngene
  • WuXi AppTec

Western Europe:

  • ICON Plc
  • OPIS
  • Pierrel Research International AG
  • Smerud Medical Research

Eastern Europe:

  • BioEq
  • Cromos Pharma
  • MatrixPharm
  • Medpace
  • OCT

South America:

  • Chiltern
  • Eurotrials
  • ICON Plc
  • Intrials
  • Omnicare
  • PAREXEL
  • PPD
  • PRA

Middle East:

  • Antaea CRO
  • ClinServ
  • INNOVA CRO
  • MCT-CRO
  • MENA Research
  • RAY CRO

Africa:

  • OnQ Research
  • Vermaak and Partners Pathologists
  • Virtus Clinical Development
  • VX Pharma
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4605298
Adroll
adroll